Skip to main content
. 2019 Jan 2;14(1):e0209353. doi: 10.1371/journal.pone.0209353

Table 2. Mild symptoms and adverse effects (AE).

Mild symptoms (self-reported) n % Mild symptoms (observed) n %
Sleep Disturbance 169 14.94 Dizziness 2 0.14
Fatigue 155 13.70 Eczema 2 0.14
Dry Mouth 100 8.84 Bleeding gums 1 0.07
Back Pain 84 7.43 Hyperventilation 1 0.07
Hunger 77 6.81 Outbreak of infection 1 0.07
Bad Breath 61 5.39 Pleuropneumonia 1 0.07
Headache 61 5.39 Tetany 1 0.07
Muscle Pain 49 4.33 Visual disorder 1 0.07
Abdominal Bloating 47 4.16
Diarrhoea 38 3.36
Sensitivity to Cold 33 2.92 AE n %
Cravings 29 2.56 Cardiac arrhythmia 3 0.21
Vertigo 28 2.48 Hyponatremia 3 0.21
Blurred Vision 23 2.03 Hospitalisation 2 0.14
Restless Legs 23 2.03 Hypoglycaemia 2 0.14
Skin Rash 19 1.68 Hypokalaemia 1 0.07
Nausea 13 1.15 Gout 1 0.07
Palpitation 13 1.15 Vomiting 1 0.07
Dyspepsia 12 1.06 Spasmodic abdominal pain 1 0.07
Muscular cramp 4 0.35

Out of the total of 1422 a group of 1311 subjects completed and returned the daily questionnaire to self-record mild symptoms. In contrast to the observed symptoms and AE, self-reported mild symptoms were recorded if a particular symptom was experienced by the same person more than 3 times during the fasting period. The observed symptoms and AE were documented during the daily nurse visit and/or the medical visit for all subjects. The same subject could mention more than one symptom or AE.